We are live on ! Find out more
XBIOW

Xenetic Biosciences, Inc. Warrants
XBIOW

Delisted

XBIOW was delisted on the 16th of July, 2024.

Back to rankings

1 hedge funds and large institutions have $1K invested in Xenetic Biosciences, Inc. Warrants in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$821

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K +$821 +1,270 New

XBIOW Hedge Fund Activity: Q2 2020 in Review

1 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences, Inc. Warrants (XBIOW) for Q2 2020, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new XBIOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $821.

  • 1 institutional investor held Xenetic Biosciences, Inc. Warrants (XBIOW) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1K of Xenetic Biosciences, Inc. Warrants stock for Q2 2020.
  • 1 fund opened new Xenetic Biosciences, Inc. Warrants positions in Q2 2020 and 0 closed out, a net change of +1 holder.
  • The largest Xenetic Biosciences, Inc. Warrants buyer in Q2 2020 was UBS Group, an estimated $821 added.

Based on aggregated 13F filings for Q2 2020.